Immuneering
Cambridge
About Immuneering
Immuneering is a biopharmaceutical company with an emerging pipeline focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying its deep knowledge of translational bioinformatics to every stage of the drug development process. It has more than a decade of experience in translational bioinformatics and generating insights into drug mechanisms of action and patient treatment responses.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Total funding: $337.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Sep 2025)
- Ticker: nasdaq:IMRX
- Website: immuneering.com
- Phone: +1 617 500 8080
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/immuneering-53286 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.